)

)

)

)

) Docket DOT-OST-1996-1826

) (former Docket 48735)

)

)

)

------------------------------~)

..,~ -:- ,r,: ".

..

BEFORE THE

DEPARTMENT OF TRANSPORTATION

. OFFICE OF THE SECRETARY

.. WASlnNGTON, D.C.

Motion of

US AIRWAYS, INC.

for confidential treatment of documents pursuant

to Rule 12 of the Rules of Practice

(Schedule B-7 and B-43 ofFonn 41)

MOTION OF US AIRWAYS, INC.

FOR CONFIDENTIAL TREATMENT

Communications with respect to this document should be sent to:

Howard Kass

Vice President - Regulatory Affairs

Abigail Donovan

Director, Congressional and Federal Affairs

US Airways, Inc.

1401 H Street, NW, Suite 1075

Washington, DC 20005

(202) 326-5153

howard.kass@usairways.com

benjamin.slocum@usairways.com

March 28, 2014

, !.: i.
BEFORE THE

DEPARTMENT OF TRANSPORTATION

OFFICE OF THE SECRETARY

WASHINGTON, D.C.

)

)

)

)

) Docket DOT-OST-1996-1826

) (former Docket 48735)

)

) March 28, 2014

)

------------------------------.)

Motion of

US AIRWAYS, INC.

for confidential treatment of documents pursuant

to Rule 12 of the Rules of Practice

(Schedule B-7 and B-43 of Form 41)

MOTION OF US AIRWAYS, INC.

FOR CONFIDENTIAL TREATMENT

Pursuant to Rule 12 of the Department's Rules of Practice (14 C.F.R. § 302.12),

US Airways, Inc. ("US Airways") hereby requests confidential treatment of certain information

contained in Schedule B-7 - Airframe and Aircraft Engine Acquisitions and Retirements of

US Airways ' Form 41 filing for the quarter ended December 31, 2013 ("Schedule B-7"), and

Schedule RA3 - Inventory of Airframes and Aircraft Engines for the year ended December 31,

2013 ("Schedule B-43"). That filing will be submitted separately herewith under seal, marked

with a request for confidential treatment pursuant to Rule 12 (§ 302.12). US Airways requests

that these data be withheld from public disclosure for a period of at least ten (10) years from the

date of their submission. In support of this request, US Airways states as follows:

The Freedom of Information Act, 5 U.S.C. § 552(b)(4), provides that confidential

commercial and financial information obtained from a private person is exempt from the

requirements of public disclosure. The information for which US Airways requests confidential

treatment is confidential and proprietary commercial and financial information obtained from

US Airways, a private party. Moreover, the public release of that information would cause US

1
Motion of US Airways,Inc. for Confidential Treatment

Airways substantial competitive and financial injury. Accordingly, the information should be

withheld from public disclosure.

The information at issue is cost, amortization/depreciation and realization data relating to

US Airways' airframes and aircraft engines as of December 31, 2013. This information is

presented in columns 11, 12, and 13 of Schedule B-7 and in columns 16 through 20 of Schedule

B-43. See Exhibit A hereto for a listing of the specific information included in Schedule B-7 and

Schedule B-43 for which confidential treatment is requested. In addition to filing Schedule B-7

and Schedule B-43 under seal, US Airways is submitting to the Office of Aviation Analysis

redacted copies of Schedule B-7 and Schedule B-43, available for public inspection, that omit the

information for which confidential treatment is requested.

The Department has previously determined that the confidential and competitivelysensitive data contained in US Airways' Schedules B-7 and B-43 are entitled to confidential

treatment. By letter of James W. Mitchell, Director, Office of Airline Statistics, the Department

granted prior US Airways' requests for confidential treatment of this same information for earlier

reporting periods and ruled that it be withheld from public disclosure for a period of ten (10)

years. The Department's reasoning applies with equal force to US Airways' present motion and

submission.

2
Motion of US Airways, Inc. for Confidential Treatment

WHEREFORE, US Airways, Inc. respectfully requests that the confidential

information contained in its Schedule B-7 and Schedule B-43 detailed above be withheld from

public disclosure for at least ten (10) years.

Respectfully submitted,

Howard Kass

Vice President - Regulatory Affairs

Abigail Donovan

Director, Congressional and Federal Affairs

US Airways, Inc.

1401 H Street, NW, Suite 1075

Washington, DC 20005

(202) 326-5153

howard.kass@usairways.com

benjamin.slocum@usairways.com

March 28, 2014

3
EXHIBIT A

Listing of Confidential Information in US Airways, Inc.' s Form 41 Filing

Schedule B-7:

TitlelDescription Location in Document Number of Pages

Cost Column (11) 3

Depreciated Cost or Column (12) 3

Amortized Value

Realization Column (13) 3

Schedule B-43:

TitlelDescription Location in Document Number of Pages

Acquired Cost or Capital Column (16) 7

Value

Allowance for Depreciation or Column (17) 7

Amortization

Depreciation Cost or Column (18) 7

Amortized Value

Estimated Residual Value Column (19) 7

Estimated Depreciation or Column (20) 7

Amortization Life (Months)